UK Parliament / Open data

Breast Cancer Drugs

Proceeding contribution from Iain Stewart (Conservative) in the House of Commons on Thursday, 26 January 2017. It occurred during Backbench debate on Breast Cancer Drugs.

I congratulate the hon. Member for Mitcham and Morden (Siobhain McDonagh) on securing this important debate and setting out her case so powerfully. I agree with pretty much everything she said. I know that several Members wish to speak, so I will not detain the House by simply repeating all those points.

My motivation in speaking today comes from a meeting I had at my constituency surgery just a few weeks ago with my constituent Joanna Mears and her husband. Like many other sufferers, they are watching our proceedings from the Public Gallery. Mrs Mears suffers from secondary breast cancer. Although, sadly, her condition is terminal, she is responding well to her existing medication and has already had more than twice the expected benefit span. When the point comes that the medication no longer has that effect, her only remaining option will be Kadcyla. Naturally, she is very concerned about NICE’s decision.

Type
Proceeding contribution
Reference
620 c511 
Session
2016-17
Chamber / Committee
House of Commons chamber
Back to top